|
US5521297A
(en)
*
|
1993-06-04 |
1996-05-28 |
Salk Institute Biotechnology/Industrial Associates |
Nucleic acids encoding human metabotropic glutamate receptors
|
|
ATE400653T1
(de)
*
|
1995-07-26 |
2008-07-15 |
Astrazeneca Ab |
Chimäre rezeptoren und verfahren zur identifizieren verbindungen mit einem aktivität als metabotropischen glutamatrezeptoren sowie verwendung solcher verbindungen in der behandlung von neurologischer erkrankungen und neurologischenstörrungen
|
|
US6221609B1
(en)
*
|
1996-07-03 |
2001-04-24 |
Eli Lilly And Company |
Isolate nucleic acid encoding human MGLUR8
|
|
US7262280B1
(en)
|
1998-04-03 |
2007-08-28 |
Nps Pharmaceuticals, Inc. |
G-protein fusion receptors and constructs encoding same
|
|
EP1066325A1
(en)
*
|
1998-04-03 |
2001-01-10 |
Nps Pharmaceuticals, Inc. |
G-protein fusion receptors and chimeric gaba b? receptors
|
|
AU772105B2
(en)
*
|
1998-08-18 |
2004-04-08 |
Johns Hopkins University School Of Medicine, The |
Homer interacting proteins
|
|
EP1662255A3
(en)
*
|
1998-08-18 |
2006-09-13 |
The Johns Hopkins University School Of Medicine |
Homer interacting proteins
|
|
CN1283798C
(zh)
*
|
1998-08-31 |
2006-11-08 |
都柏林伊丽莎白女皇神学院 |
凝固酶阴性葡萄球菌的多肽及多核苷酸
|
|
US20030185754A1
(en)
*
|
2001-01-16 |
2003-10-02 |
Genset, S.A. |
Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
|
|
US20030166554A1
(en)
*
|
2001-01-16 |
2003-09-04 |
Genset, S.A. |
Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
|
|
US6620850B2
(en)
*
|
2001-09-19 |
2003-09-16 |
University Of Florida |
Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
|
|
WO2003054167A2
(en)
*
|
2001-12-20 |
2003-07-03 |
Merck & Co., Inc. |
Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
|
|
EP1531855A4
(en)
*
|
2002-01-10 |
2009-07-22 |
Osteotrophin Llc |
TREATMENT OF BONE DISEASES WITH SKELETTAL ANABOLIKA
|
|
US20060252922A1
(en)
*
|
2002-12-04 |
2006-11-09 |
Macina Roberto A |
Compositions, splice variants and methods relating to colon specific genes and proteins
|
|
US20050186658A1
(en)
*
|
2003-10-17 |
2005-08-25 |
Nps Pharmaceuticals, Inc. |
Chimeric metabotropic glutamate receptors and uses thereof
|
|
WO2005073730A1
(en)
*
|
2004-01-31 |
2005-08-11 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 8 (mglur8)
|
|
EP1805200B1
(en)
*
|
2004-10-14 |
2012-01-04 |
Carnegie Institution Of Washington |
Neurotransmitter sensors and methods of using the same
|
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
US8889950B2
(en)
*
|
2006-07-28 |
2014-11-18 |
The George Washington University |
Repression of AtGLR3.2 increases plant biomass
|
|
US7424876B2
(en)
*
|
2006-10-06 |
2008-09-16 |
Ford Global Technologies, Llc |
Pushrod engine with multiple independent lash adjusters for each pushrod
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
RS51660B
(sr)
|
2007-09-14 |
2011-10-31 |
Ortho-Mcneil-Janssen Pharmaceuticals Inc. |
1`,3`-disupstituisani-4-fenil-3,4,5,6-tetrahidro-2h, 1`h-[1,4`] bipiridinil-2`-oni
|
|
WO2009079566A2
(en)
*
|
2007-12-18 |
2009-06-25 |
Acumen Pharmaceuticals, Inc. |
Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
|
|
AU2009274482A1
(en)
*
|
2008-05-20 |
2010-01-28 |
Eos Neuroscience, Inc. |
Vectors for delivery of light-sensitive proteins and methods of use
|
|
EP2344470B1
(en)
|
2008-09-02 |
2013-11-06 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
|
JP5690277B2
(ja)
|
2008-11-28 |
2015-03-25 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
KR20120035158A
(ko)
|
2009-05-12 |
2012-04-13 |
얀센 파마슈티칼즈, 인코포레이티드 |
1,２,４?트리아졸로［４,３?ａ］피리딘 유도체 및 ｍＧｌｕＲ２ 수용체의 양성 알로스테릭 조절자로서의 그의 용도
|
|
US8937060B2
(en)
|
2009-05-12 |
2015-01-20 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
|
|
CN103298809B
(zh)
|
2010-11-08 |
2016-08-31 |
杨森制药公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
|
EP2643320B1
(en)
|
2010-11-08 |
2015-03-04 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
CA2814996C
(en)
|
2010-11-08 |
2019-10-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
HRP20191646T1
(hr)
|
2014-01-21 |
2019-12-13 |
Janssen Pharmaceutica Nv |
Kombinacije koje sadržavaju pozitivne alosteričke modulatore ili ortosteričke agoniste metabotropnog glutamatergičnog receptora podtip 2 i njihova uporaba
|
|
CN109999033B
(zh)
|
2014-01-21 |
2022-12-23 |
詹森药业有限公司 |
包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
|
|
MX2018001566A
(es)
|
2015-08-07 |
2019-04-25 |
Imaginab Inc |
Construcciones de union a antigeno para moleculas diana.
|
|
WO2018147960A1
(en)
|
2017-02-08 |
2018-08-16 |
Imaginab, Inc. |
Extension sequences for diabodies
|
|
AU2018256436B2
(en)
|
2017-04-19 |
2024-12-05 |
Board Of Regents, The University Of Texas System |
Immune cells expressing engineered antigen receptors
|
|
EP3755349A4
(en)
|
2018-02-21 |
2021-11-17 |
Board of Regents, The University of Texas System |
PROCESS FOR ACTIVATION AND EXPANSION OF NATURAL KILLER CELLS AND THEIR USES
|